Village Farms International (VFF) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
28 Apr, 2026Leadership in controlled environment agriculture
Over 36 years of expertise in controlled environment agriculture, focusing on plant-based consumer products and global cannabinoid opportunities.
Among North America's largest and longest-operating CEA growers, with three decades of mega-scale greenhouse operations.
750+ years of combined master grower experience and strong relationships with major grocers and retailers.
Key investment highlights
Unrivaled cultivation expertise and proven track record in plant-based consumer goods.
Recent transformative transaction unlocking growth and shareholder value.
One of the world's largest scalable cannabis platforms, positioned for global demand.
Industry-leading cost of production and EU-GMP certification provide competitive advantages.
Strong balance sheet supports continued accretive growth investments.
Transformative transaction and portfolio evolution
Privatized majority of legacy fresh produce business in May 2025 via a joint venture, receiving $40M cash and 37.9% equity in Vanguard Food.
Sold 80 acres of Texas greenhouse assets as part of the transaction.
Portfolio includes major brands and operations in cannabis and hemp-derived products, with $211M gross sales YTD 2025 and $30M net income (including discontinued operations).
Latest events from Village Farms International
- Annual meeting to elect directors, approve pay, and appoint auditor, with strong governance focus.VFF
Proxy filing29 Apr 2026 - Record 2025 profitability, 70% cannabis sales growth, and strong cash position support expansion.VFF
Q4 202530 Mar 2026 - All director nominees and motions were approved, with final results to be published.VFF
AGM 20243 Feb 2026 - Record sales growth in Canadian cannabis and produce, but net loss widened by U.S. impairment.VFF
Q2 20242 Feb 2026 - Q3 sales up 20%, driven by Canadian cannabis, fresh produce, and international growth.VFF
Q3 202416 Jan 2026 - All director nominees and motions were approved, with final results to be published.VFF
AGM 20256 Jan 2026 - Full-year sales up 18% to CAD 336M; international medicinal sales to triple in 2025.VFF
Q4 202425 Dec 2025 - Plans to raise up to $200 million for growth via a multi-security shelf registration.VFF
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor, with focus on governance and diversity.VFF
Proxy Filing2 Dec 2025